Spain · Delayed Price · Currency is EUR BME:PRS Statistics
Total Valuation
BME:PRS has a market cap or net worth of EUR 476.98 million. The enterprise value is 1.22 billion.
| Market Cap | 476.98M |
| Enterprise Value | 1.22B |
Important Dates
The last earnings date was Tuesday, October 28, 2025.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:PRS has 1.35 billion shares outstanding.
| Current Share Class | 1.35B |
| Shares Outstanding | 1.35B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.98% |
| Owned by Institutions (%) | 5.06% |
| Float | 530.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 53.64 |
| PS Ratio | 0.54 |
| PB Ratio | -1.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.08 |
| P/OCF Ratio | 3.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.56, with an EV/FCF ratio of 10.48.
| EV / Earnings | -54.22 |
| EV / Sales | 1.38 |
| EV / EBITDA | 7.56 |
| EV / EBIT | 13.02 |
| EV / FCF | 10.48 |
Financial Position
The company has a current ratio of 1.22
| Current Ratio | 1.22 |
| Quick Ratio | 1.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.34 |
| Debt / FCF | 7.44 |
| Interest Coverage | 1.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 7.14% |
| Return on Invested Capital (ROIC) | 12.17% |
| Return on Capital Employed (ROCE) | 20.14% |
| Revenue Per Employee | 121,790 |
| Profits Per Employee | -3,094 |
| Employee Count | 7,295 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 7.94 |
Taxes
In the past 12 months, BME:PRS has paid 31.17 million in taxes.
| Income Tax | 31.17M |
| Effective Tax Rate | 336.63% |
Stock Price Statistics
The stock price has increased by +4.12% in the last 52 weeks. The beta is 0.80, so BME:PRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +4.12% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 0.38 |
| Relative Strength Index (RSI) | 39.83 |
| Average Volume (20 Days) | 127,574 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:PRS had revenue of EUR 888.46 million and -22.57 million in losses. Loss per share was -0.02.
| Revenue | 888.46M |
| Gross Profit | 461.84M |
| Operating Income | 94.85M |
| Pretax Income | 9.26M |
| Net Income | -22.57M |
| EBITDA | 136.65M |
| EBIT | 94.85M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 133.00 million in cash and 869.00 million in debt, giving a net cash position of -736.00 million or -0.55 per share.
| Cash & Cash Equivalents | 133.00M |
| Total Debt | 869.00M |
| Net Cash | -736.00M |
| Net Cash Per Share | -0.55 |
| Equity (Book Value) | -389.00M |
| Book Value Per Share | -0.30 |
| Working Capital | 78.00M |
Cash Flow
In the last 12 months, operating cash flow was 128.81 million and capital expenditures -11.96 million, giving a free cash flow of 116.84 million.
| Operating Cash Flow | 128.81M |
| Capital Expenditures | -11.96M |
| Free Cash Flow | 116.84M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 51.98%, with operating and profit margins of 10.68% and -2.54%.
| Gross Margin | 51.98% |
| Operating Margin | 10.68% |
| Pretax Margin | 1.04% |
| Profit Margin | -2.54% |
| EBITDA Margin | 15.38% |
| EBIT Margin | 10.68% |
| FCF Margin | 13.15% |
Dividends & Yields
BME:PRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -4.73% |
| FCF Yield | 24.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 22, 2015. It was a reverse split with a ratio of 0.0333333333.
| Last Split Date | May 22, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.0333333333 |
Scores
BME:PRS has an Altman Z-Score of 1.7 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.7 |
| Piotroski F-Score | 6 |